[18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism

J Comput Assist Tomogr. 2007 Sep-Oct;31(5):770-2. doi: 10.1097/RCT.0b013e318031f55c.

Abstract

Congenital hyperinsulinism can be divided into diffuse or focal form. The treatment and outcome depend on distinguishing between the 2 forms. Pancreatic venous sampling was the only method available to localize the insulin secretion. [F]Fluoro-levodopa, 3,4-dihydroxy-L-phenylalanine positron emission tomography/computed tomography is a noninvasive imaging investigation and increasingly used to determine the type of hyperinsulinism preoperatively. We present a case of diffuse form of congenital hyperinsulinism demonstrated by the [F]levodopa, 3,4-dihydroxy-L-phenylalanine positron emission tomography/computed tomography preoperatively and review the literature.

Publication types

  • Case Reports

MeSH terms

  • Congenital Hyperinsulinism / diagnostic imaging*
  • Diagnosis, Differential
  • Dihydroxyphenylalanine / analogs & derivatives*
  • Female
  • Fluorine Radioisotopes*
  • Humans
  • Infant
  • Positron-Emission Tomography*
  • Radiopharmaceuticals
  • Tomography, X-Ray Computed*

Substances

  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • fluorodopa F 18
  • Dihydroxyphenylalanine